1-2 of 2
Kyle Robinson, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Outcomes of Obinutuzumab Therapy across Non-Hodgkin Lymphoma Subtypes

Mitchell E. Hughes, PharmD, Esin C. Namoglu, B.S., Connie Suen, PharmD, Stephen J Schuster, MD, Jakub Svoboda, MD, Daniel J. Landsburg, MD, Stefan K. Barta, MD MRCP, MS, James N. Gerson, MD, Kyle Robinson, MD, Elise A. Chong, MD, Joanna M Rhodes, MD, Emily C. Ayers, MD, Alison W. Loren, MD MSCE, Edward A. Stadtmauer, MD FACP, Sunita Dwivedy Nasta, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5247.
https://doi.org/10.1182/blood-2019-128148
Published: 2019
Journal Articles

Clinical Outcomes of Venetoclax Therapy in Patients with Relapsed/Refractory (r/r) Non Hodgkin Lymphomas (NHL)

Mitchell E. Hughes, PharmD, Daniel J. Landsburg, MD, Daniel J Rubin, PharmD, Stephen J. Schuster, MD, Jakub Svoboda, MD, Donald Edward Tsai, MD PhD, Kyle Robinson, MD, Saar I. Gill, MDPhD, Anthony R. Mato, MDMSCE, James Nathan Gerson, MD, Danielle Land, CRNP, Brenda Shelly, CRNP, Alicia McLeish, CRNP, Allison Rago, CRNP, Jennifer Gill, CRNP, Kristy Walsh, BS, Tanya Latorre, RN, Jessica K. Altman, MD, Colleen Timlin, PharmD, Donna Capozzi, PharmD, BCOP, Sunita Dwivedy Nasta, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1706.
https://doi.org/10.1182/blood-2018-99-111194
Published: 2018